Understanding head and neck cancer in children
Malignant Head and Neck Tumors in Children: A Retrospective Study
This study looks at the medical records of children with head and neck cancer to see how common these cancers are and what treatments worked best for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT02557048 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze demographic characteristics, histopathologies, and treatment outcomes of pediatric patients diagnosed with malignant head and neck tumors at the South Egypt Cancer Institute. It involves a retrospective review of medical records from patients treated between January 2001 and December 2015. The study will gather clinico-laboratory data to identify the frequency and incidence of various head and neck malignancies in children, focusing on factors such as age, gender, and tumor site preferences.
Who should consider this trial
Good fit: Ideal candidates for this study are children under 19 years old diagnosed with a primary malignant tumor of the head and neck.
Not a fit: Patients over 18 years old or those with malignancies primarily arising from the bone marrow or central nervous system will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of pediatric head and neck cancers, leading to improved diagnosis and treatment strategies.
How similar studies have performed: While there is limited data on childhood head and neck cancers, similar studies have provided valuable insights into pediatric oncology, suggesting potential for meaningful findings in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients whose age less than 19 years. * Patients diagnosed with a primary malignant tumor of the head \& neck. Exclusion Criteria: * Patients whose age more than 18 years. * Patients diagnosed with a malignant disease primarily arising from the bone marrow. * Patients diagnosed with tumors of the central nervous system. * Patients diagnosed with retinoblastoma.
Where this trial is running
Assiut
- Assiut University — Assiut, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.